PubRank

B Tarlatzis

Author PubWeight™ 39.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011 5.49
2 Fertility and ageing. Hum Reprod Update 2005 2.68
3 I. The moral status of the pre-implantation embryo. Hum Reprod 2001 1.73
4 Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update 2005 1.66
5 ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. Hum Reprod 2008 1.59
6 Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women. Hum Reprod 2004 1.53
7 High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. Hum Reprod 1999 1.41
8 GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Hum Reprod 2012 1.01
9 ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. Hum Reprod 2007 0.97
10 Oocyte cryopreservation for age-related fertility loss. Hum Reprod 2012 0.95
11 Association of oestrogen receptor alpha polymorphisms and androgen receptor CAG trinucleotide repeats with male infertility: a study in 109 Greek infertile men. Int J Androl 2002 0.95
12 ESHRE task force on ethics and law 15: cross-border reproductive care. Hum Reprod 2008 0.94
13 ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod 2006 0.94
14 Lifestyle-related factors and access to medically assisted reproduction. Hum Reprod 2010 0.93
15 ESHRE Task Force on Ethics and Law 12: oocyte donation for non-reproductive purposes. Hum Reprod 2007 0.92
16 Providing infertility treatment in resource-poor countries. Hum Reprod 2009 0.90
17 ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues. Hum Reprod 2014 0.88
18 ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons. Hum Reprod 2013 0.87
19 Intrafamilial medically assisted reproduction. Hum Reprod 2011 0.84
20 IFFS expert group report on the Whittemore study related to the risk of ovarian cancer associated with the use of infertility agents. Hum Reprod 1993 0.84
21 Improved techniques for separating motile spermatozoa from human semen. II. An atraumatic centrifugation method. Int J Androl 1984 0.83
22 ESHRE Task Force on Ethics and Law 10: surrogacy. Hum Reprod 2005 0.83
23 Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. Reprod Biomed Online 2010 0.81
24 Taskforce 5: preimplantation genetic diagnosis. Hum Reprod 2003 0.80
25 Laparoscopic management of unexpected borderline ovarian tumors in women of reproductive age. Eur J Gynaecol Oncol 2012 0.80
26 The periovulatory and luteal phase of conception cycles following in vitro fertilization and embryo transfer. Fertil Steril 1984 0.80
27 Beta-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos. Hum Reprod 1992 0.78
28 II. The cryopreservation of human embryos. Hum Reprod 2001 0.78
29 Human chorionic gonadotropin stimulation of estradiol production and androgen antagonism of gonadotropin-stimulated responses in cultured human granulosa-luteal cells. J Clin Endocrinol Metab 1986 0.78
30 Pituitary-testicular axis in men with beta-thalassaemia major. Hum Reprod 1996 0.78
31 Preimplantation diagnosis. Hum Reprod 1992 0.78
32 Ambiguous genitalia, 45,X/46,XY mosaic karyotype, and Y chromosome microdeletions in a 17-year-old man. Fertil Steril 2001 0.78
33 Paternal sperm concentration and growth and cognitive development in children born with a gestational age more than 32 weeks after assisted reproductive therapy. Hum Reprod 2006 0.77
34 Azoospermia: clinical, hormonal, and biochemical investigation. Arch Androl 1997 0.76
35 Congenital obstructive azoospermia in a man with Marfan syndrome. Fertil Steril 2001 0.75
36 Operative treatment of gynaecologic diseases in puberty: seven years of experience. Clin Exp Obstet Gynecol 2013 0.75
37 Obstetric outcome in adolescence: a single centre experience over seven years. Clin Exp Obstet Gynecol 2013 0.75
38 Seminal plasma transferrin in infertile men. Arch Androl 1992 0.75
39 Psychological interviews in screening couples undergoing in vitro fertilization. Ann N Y Acad Sci 1985 0.75
40 Galanin in the amniotic fluid and neonatal birth weight: a prospective observational study. J Matern Fetal Neonatal Med 2013 0.75
41 Pregnancy outcome after assisted fertilization--a short survey. Int J Androl 1997 0.75
42 Application of image analysis cytometry in follicular fluid cells obtained from in-vitro fertilization cycles: relationships to patient's age, oocyte maturity, fertilizability and in-vitro fertilization outcome. Hum Reprod 1996 0.75
43 Improved techniques for collecting motile spermatozoa from human semen. I. A self-migratory method. Int J Androl 1984 0.75
44 Spontaneous pregnancy following therapeutic approach of an infertile man with aspermia/obstructive azoospermia. Arch Androl 1999 0.75
45 Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of embryos. Hum Reprod 2005 0.75